患有心力衰竭的患者的治疗负担
Jamie L Smith1, Jill M Killian2, Nathan Shippee3
1Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery Mayo Clinic Rochester MN USA.
Journal of the American Heart Association
|May 15, 2025
概括
心力衰竭患者的高治疗负担与健康状况恶化和死亡风险增加有关. 针对BoT和健康状况的干预措施对于改善患者的治疗结果和生活质量至关重要.
科学领域:
- 心脏病学 心脏病学
- 医疗保健服务研究 医疗服务研究
- 心理社会医学 心理社会医学
背景情况:
- 心力衰竭 (HF) 管理中的自我护理带来了相当大的日常工作量和治疗负担.
- 了解这种治疗负担 (BoT) 的特征和结果对于优化患者护理至关重要.
研究的目的:
- 评估与心力衰竭患者治疗负担 (BoT) 相关的临床和心理社会特征.
- 检查BoT与不良健康结果 (包括死亡率和住院病例) 之间的关系.
主要方法:
- 一项包括609名明尼苏达州东南部心力衰竭患者在内的队列研究,他们完成了关于BoT和相关结构的验证调查.
- 参与者根据BOT分数被分为分层.
- 统计分析包括临床变量协会的多项逻辑回归和Cox比例危险/Andersen-Gill模型,用于分析BoT对死亡率和住院病人的影响.
主要成果:
- 较高的BoT与较差的健康状况相关,抑郁症状增加,弹性降低,社会支持减少,药物坚持较低,健康素养降低.
- 研究人员观察到,增加Bot三角形和更高的一年死亡率和住院率之间存在剂量反应关系.
- 在调整了健康状况后,BoT与死亡或住院风险之间的显著关联减弱了.
结论:
- 心力衰竭的治疗负担受到临床和心理社会因素的结合的影响.
- 升高的BoT作为患者的指标,具有更高的不良结果风险,主要是由于他们的健康状况受到损害.
- 这些发现为开发旨在减少患者工作量和提高心力衰竭管理中的生活质量的干预措施提供了基础.
相关概念视频
01:22Heart Failure Drugs: β-Blockers
300
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
300
01:17Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
01:22Heart Failure Drugs: Diuretics
313
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
313
01:26Imbalances in Cardiac Output
1.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
356
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
356
01:26Heart Failure Drugs: Inotropic Agents
481
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
481